- Recent Funding
- Investors
- Jazz Pharmaceuticals
Jazz Pharmaceuticals portfolio
Jazz Pharmaceuticals has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Setara Biosciences's $90M Series A round in October 2026, alongside EcoR1 Capital, Euclidean Capital, Droia Ventures and 3 others. That company is in Health and bio.
What Jazz Pharmaceuticals invests in
- Health and bio · 1 · 100%
How Jazz Pharmaceuticals invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $90M |
Jazz Pharmaceuticals portfolio companies
SSetara Biosciences$90MSeries A · Oct 2026
| Company | Round with Jazz Pharmaceuticals | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $90M | $90M | Oct 30, 2026 Series A |
Most frequent co-investors
DDeerfield1 shared round · last Oct 30, 2026
EEcoR1 Capital1 shared round · last Oct 30, 2026
- EEuclidean Capital1 shared round · last Oct 30, 2026
DDroia Ventures1 shared round · last Oct 30, 2026
RRegeneron Ventures1 shared round · last Oct 30, 2026
CCanaan Partners1 shared round · last Oct 30, 2026
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Jazz Pharmaceuticals. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Jazz Pharmaceuticals, which is a subset of its real portfolio. API: /api/v1/investors/jazz-pharmaceuticals (get a free API key). More: the most active VC firms and new venture capital funds.